Immersion Investment Partners highlighted Red Violet, Inc. in its Q2 2026 investor letter, describing a violent first-quarter contraction followed by a snapback. The firm stated that Red Violet's core identity offering is not exposed to AI threats and benefits from AI trends through its custom-built CORE platform. Management delivered expectation-beating top- and bottom-line results, and the company announced Forewarn's entry into the healthcare industry, with an immediately addressable revenue opportunity estimated at $50 million to $75 million. Immersion Investment Partners noted that even modest incremental revenue from Forewarn would significantly increase profitability. Red Violet closed at $65.65 per share on August 10, 2026, with a market capitalization of $1.05 billion.
Red Violet IncForewarn's entry into healthcare with $50-75M addressable revenue opportunity boosts demand.
